Register for real-time alerts, custom portfolio, and market movers
Period:
Draw Mode:
| Volume | 42,450 |
|
|||||
| News | - | ||||||
| Day High | 2.33 | Low High |
|||||
| Day Low | 2.18 | ||||||
| Share Name | Share Symbol | Market | Stock Type |
|---|---|---|---|
| Vapotherm Inc | VAPO | NYSE | Common Stock |
| Price Change | Price Change % | Share Price | Last Trade
|
|
|---|---|---|---|---|
| -0.10 | -4.41% | 2.17 | 15:00:04 |
| Open Price | Low Price | High Price | Close Price | Previous Close |
|---|---|---|---|---|
| 2.26 | 2.18 | 2.33 | 2.17 | 2.27 |
| Trades | Shares Traded | VWAP | Financial Volume | Average Volume | 52 Week Range |
|---|---|---|---|---|---|
| 277 | 42,450 | US$ 2.22 | US$ 94,337 | - | 2.18 - 23.6544 |
| Last Trade | Type | Quantity | Price | Currency |
|---|---|---|---|---|
| 15:10:00 | 1,345 | US$ 2.17 | USD |
Vapotherm Inc Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| 13.69M | 6.14M | - | 66.8M | -113.26M | -18.45 | - |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | - | - | - |
Vapotherm News
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical VAPO Price Data
| Period † | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 3.29 | 3.44 | 2.18 | 2.61 | 28,662 | -1.12 | -34.04% |
| 1 Month | 2.52 | 3.44 | 2.18 | 2.66 | 31,937 | -0.35 | -13.89% |
| 3 Months | 3.50 | 3.775 | 2.18 | 2.68 | 51,650 | -1.33 | -38.0% |
| 6 Months | 5.044 | 7.44 | 2.18 | 3.71 | 139,536 | -2.87 | -56.98% |
| 1 Year | 13.44 | 23.6544 | 2.18 | 8.30 | 202,948 | -11.27 | -83.85% |
| 3 Years | 216.08 | 307.68 | 2.18 | 84.12 | 265,599 | -213.91 | -99.0% |
| 5 Years | 168.00 | 437.824 | 2.18 | 135.88 | 288,919 | -165.83 | -98.71% |
Vapotherm Description
| Vapotherm Inc is a medical technology company based in the United States. It is mainly engaged in the development and commercialization of its proprietary Hi-VNI technology products that are used to treat patients of all ages suffering from respiratory distress. The company offers four versions of its Precision Flow systems: Precision Flow Hi-VNI, Precision Flow Plus, Precision Flow Classic, and Precision Flow Heliox. It generates revenue primarily from sales of proprietary Precision Flow systems to hospitals through a direct sales organization in the United States and distributors in select countries outside of the United States. |
